| SC 13D/A | 2022-12-30 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 4,552,068 | 4.6% | EDGAR |
| SC 13G | 2022-09-02 | Soleus Capital Master Fund, L.P. | Adverum Biotechnologies, Inc. | 4,982,789 | 5.0% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Adverum Biotechnologies, Inc. | 3,323,843 | 3.4% | EDGAR |
| SC 13G | 2022-05-10 | BML Investment Partners, L.P. | Adverum Biotechnologies, Inc. | 4,950,000 | 5.0% | EDGAR |
| SC 13G | 2022-04-11 | FMR LLC | Adverum Biotechnologies, Inc. | 10,873,853 | 11.0% | EDGAR |
| SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | Adverum Biotechnologies, Inc. | 7,554,817 | 7.7% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | Adverum Biotechnologies, Inc. | 6,950,000 | 7.1% | EDGAR |
| SC 13G/A | 2022-02-11 | ORBIMED ADVISORS LLC | Adverum Biotechnologies, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-11 | REGENERON PHARMACEUTICALS, INC. | Adverum Biotechnologies, Inc. | 1,809,098 | 1.8% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Adverum Biotechnologies, Inc. | 7,346,822 | 7.5% | EDGAR |
| SC 13G/A | 2021-10-12 | STATE STREET CORP | Adverum Biotechnologies, Inc. | - | 2.1% | EDGAR |
| SC 13G | 2021-09-10 | STATE STREET CORP | Adverum Biotechnologies, Inc. | - | 10.4% | EDGAR |
| SC 13G | 2021-08-16 | RA CAPITAL MANAGEMENT, L.P. | Adverum Biotechnologies, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2021-04-16 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 6,552,068 | 6.7% | EDGAR |
| SC 13D/A | 2021-04-09 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 6,552,068 | 6.7% | EDGAR |
| SC 13D | 2021-03-18 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 6,052,068 | 6.2% | EDGAR |
| SC 13G | 2021-02-16 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 5,101,787 | 5.2% | EDGAR |
| SC 13G | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | Adverum Biotechnologies, Inc. | 9,502,383 | 9.7% | EDGAR |
| SC 13G/A | 2021-02-12 | Avoro Capital Advisors LLC | Adverum Biotechnologies, Inc. | 8,000,000 | 8.2% | EDGAR |
| SC 13G/A | 2021-02-12 | ORBIMED ADVISORS LLC | Adverum Biotechnologies, Inc. | 4,845,247 | 5.0% | EDGAR |